New Drug - Omacetaxine (2 x Clinical Trials to start) - Sunday Times article

[Guest guest]

Sunday Times Article 2nd May 2009 - Robyn Riley Journalist

I could not scan and post - so I have typed out in full.

Sue (Aussie)

______________________________________________________________

Omacetaxine Drug (Recruiting for Trial) 2009 -

New Drug (Omacetaxine) Australian Invention

Dr Tony Schwater of the Alfred Hospital in Melbourne is about to start two

clinical trials of omaxetaxine.

He is recruiting and said patients who had the gene mutation, or who were

resistant to other therapies should speak with their haemotologists and then

contact his office on (03) 9899 4060.

" It is too early to say this drug is a cure, but it offers hope and is a

wonderful thing to come out of our local biotech industry, " Prof Schwarer said.

___________________________________________________

In the Article " Blood Cancer Hope " Sunday Times 2nd May 2009 - Journalist Robyn

Riley

This is part of the transcript of the above.

An Australian biotechnology company had developed a drug of CML - a discovery

that offers hope of a cure for the blood cancer.

The drug - omacetaxine - is the only one tested that can kill CML stem cells,

according to ChemGenex Chief Greg Collier.

At least two patients in the international clinical trials, including a

n, are in remission.

Dr Collier said 80 percent of patients in the trials conducted in the US, Europe

and Australia now had normal white blood cells and one in five had a return of

normal bone marrow.

" This is exciting because it targets those patients hwo have no other options "

Dr Collier said.

ChemGenex Pharmaceuticals said the drug was in final clinical trials, and it was

confident of approval by the US regulators, the Food and Drug Administration,

within this year (2009).

The FDA has helped fast track omaxetaxine because it is the only treatment

available to some CML patients with a specific gene mutation.

CML is a cancer of the blood cells. The bone marrow of patients with this

disease is replaced with malignant leukemic cells.

Three drugs are available to treat the disease, but some do not respond to

existing treatments. Omacetaxine targets these patients.

______________________________________________________

If you wish to register for the drug Trial

Contact your haemotologist, discuss, and then contact Prof Schwarer's office on

Australia (03) 9899 4060.

_______________________________________________________

Exciting times

[Guest guest]

Ooops!! Professors Names if Prof. Tony Schwarer from The Alfred Hospital in

Melbourne and not Schwater - that was my fingers doing their own thing.

Sue

>

> Sunday Times Article 2nd May 2009 - Robyn Riley Journalist

>

> I could not scan and post - so I have typed out in full.

>

> Sue (Aussie)

> ______________________________________________________________

>

>

>

> Omacetaxine Drug (Recruiting for Trial) 2009 -

>

>

> New Drug (Omacetaxine) Australian Invention

>

> Dr Tony Schwater of the Alfred Hospital in Melbourne is about to start two

clinical trials of omaxetaxine.

>

> He is recruiting and said patients who had the gene mutation, or who were

resistant to other therapies should speak with their haemotologists and then

contact his office on (03) 9899 4060.

>

> " It is too early to say this drug is a cure, but it offers hope and is a

wonderful thing to come out of our local biotech industry, " Prof Schwarer said.

>

> ___________________________________________________

>

> In the Article " Blood Cancer Hope " Sunday Times 2nd May 2009 - Journalist

Robyn Riley

>

> This is part of the transcript of the above.

>

> An Australian biotechnology company had developed a drug of CML - a discovery

that offers hope of a cure for the blood cancer.

>

> The drug - omacetaxine - is the only one tested that can kill CML stem cells,

according to ChemGenex Chief Greg Collier.

>

> At least two patients in the international clinical trials, including a

n, are in remission.

>

> Dr Collier said 80 percent of patients in the trials conducted in the US,

Europe and Australia now had normal white blood cells and one in five had a

return of normal bone marrow.

>

> " This is exciting because it targets those patients hwo have no other options "

Dr Collier said.

>

> ChemGenex Pharmaceuticals said the drug was in final clinical trials, and it

was confident of approval by the US regulators, the Food and Drug

Administration, within this year (2009).

>

> The FDA has helped fast track omaxetaxine because it is the only treatment

available to some CML patients with a specific gene mutation.

>

> CML is a cancer of the blood cells. The bone marrow of patients with this

disease is replaced with malignant leukemic cells.

>

> Three drugs are available to treat the disease, but some do not respond to

existing treatments. Omacetaxine targets these patients.

>

> ______________________________________________________

>

> If you wish to register for the drug Trial

> Contact your haemotologist, discuss, and then contact Prof Schwarer's office

on Australia (03) 9899 4060.

>

> _______________________________________________________

>

> Exciting times

>

[Guest guest]

My oncologist said it is an old drug that is coming back for

TKI refractory CML, they trying to get an indication for T315I

mutation.

Matt

Captain, CML Army in Fliorida

[ ] Re: New Drug - Omacetaxine (2 x Clinical Trials to start) -

Sunday Times article

Ooops!! Professors Names if Prof. Tony Schwarer from The Alfred Hospital in

Melbourne and not Schwater - that was my fingers doing their own thing.

Sue

>

> Sunday Times Article 2nd May 2009 - Robyn Riley Journalist

>

> I could not scan and post - so I have typed out in full.

>

> Sue (Aussie)

> __________________________________________________________

>

>

>

> Omacetaxine Drug (Recruiting for Trial) 2009 -

>

>

> New Drug (Omacetaxine) Australian Invention

>

> Dr Tony Schwater of the Alfred Hospital in Melbourne is about to start two

clinical trials of omaxetaxine.

>

> He is recruiting and said patients who had the gene mutation, or who were

resistant to other therapies should speak with their haemotologists and then

contact his office on (03) 9899 4060.

>

> " It is too early to say this drug is a cure, but it offers hope and is a

wonderful thing to come out of our local biotech industry, " Prof Schwarer said.

>

> ___________________________________________________

>

> In the Article " Blood Cancer Hope " Sunday Times 2nd May 2009 - Journalist

Robyn Riley

>

> This is part of the transcript of the above.

>

> An Australian biotechnology company had developed a drug of CML - a discovery

that offers hope of a cure for the blood cancer.

>

> The drug - omacetaxine - is the only one tested that can kill CML stem cells,

according to ChemGenex Chief Greg Collier.

>

> At least two patients in the international clinical trials, including a

n, are in remission.

>

> Dr Collier said 80 percent of patients in the trials conducted in the US,

Europe and Australia now had normal white blood cells and one in five had a

return of normal bone marrow.

>

> " This is exciting because it targets those patients hwo have no other options "

Dr Collier said.

>

> ChemGenex Pharmaceuticals said the drug was in final clinical trials, and it

was confident of approval by the US regulators, the Food and Drug

Administration, within this year (2009).

>

> The FDA has helped fast track omaxetaxine because it is the only treatment

available to some CML patients with a specific gene mutation.

>

> CML is a cancer of the blood cells. The bone marrow of patients with this

disease is replaced with malignant leukemic cells.

>

> Three drugs are available to treat the disease, but some do not respond to

existing treatments. Omacetaxine targets these patients.

>

> ______________________________________________________

>

> If you wish to register for the drug Trial

> Contact your haemotologist, discuss, and then contact Prof Schwarer's office

on Australia (03) 9899 4060.

>

> _______________________________________________________

>

> Exciting times

>

[Guest guest]

Yes Matt. HHT has been around in the 80s.  Let's hope it gets approved this time

around.

 

Jackie S.

From: mtmaynor@... <mtmaynor@...>

Subject: Re: [ ] Re: New Drug - Omacetaxine (2 x Clinical Trials to start) -

Sunday Times article

Date: Sunday, May 3, 2009, 6:34 PM

My oncologist said it is an old drug that is coming back for

TKI refractory CML, they trying to get an indication for T315I

mutation.

Matt

Captain, CML Army in Fliorida

[ ] Re: New Drug - Omacetaxine (2 x Clinical Trials to start) -

Sunday Times article

Ooops!! Professors Names if Prof. Tony Schwarer from The Alfred Hospital in

Melbourne and not Schwater - that was my fingers doing their own thing.

Sue

>

> Sunday Times Article 2nd May 2009 - Robyn Riley Journalist

>

> I could not scan and post - so I have typed out in full.

>

> Sue (Aussie)

> ____________ _________ _________ _________ _________ _________ _

>

>

>

> Omacetaxine Drug (Recruiting for Trial) 2009 -

>

>

> New Drug (Omacetaxine) Australian Invention

>

> Dr Tony Schwater of the Alfred Hospital in Melbourne is about to start two

clinical trials of omaxetaxine.

>

> He is recruiting and said patients who had the gene mutation, or who were

resistant to other therapies should speak with their haemotologists and then

contact his office on (03) 9899 4060.

>

> " It is too early to say this drug is a cure, but it offers hope and is a

wonderful thing to come out of our local biotech industry, " Prof Schwarer said.

>

> ____________ _________ _________ _________ _________ ___

>

> In the Article " Blood Cancer Hope " Sunday Times 2nd May 2009 - Journalist

Robyn Riley

>

> This is part of the transcript of the above.

>

> An Australian biotechnology company had developed a drug of CML - a discovery

that offers hope of a cure for the blood cancer.

>

> The drug - omacetaxine - is the only one tested that can kill CML stem cells,

according to ChemGenex Chief Greg Collier.

>

> At least two patients in the international clinical trials, including a

n, are in remission.

>

> Dr Collier said 80 percent of patients in the trials conducted in the US,

Europe and Australia now had normal white blood cells and one in five had a

return of normal bone marrow.

>

> " This is exciting because it targets those patients hwo have no other options "

Dr Collier said.

>

> ChemGenex Pharmaceuticals said the drug was in final clinical trials, and it

was confident of approval by the US regulators, the Food and Drug

Administration, within this year (2009).

>

> The FDA has helped fast track omaxetaxine because it is the only treatment

available to some CML patients with a specific gene mutation.

>

> CML is a cancer of the blood cells. The bone marrow of patients with this

disease is replaced with malignant leukemic cells.

>

> Three drugs are available to treat the disease, but some do not respond to

existing treatments. Omacetaxine targets these patients.

>

> ____________ _________ _________ _________ _________ ______

>

> If you wish to register for the drug Trial

> Contact your haemotologist, discuss, and then contact Prof Schwarer's office

on Australia (03) 9899 4060.

>

> ____________ _________ _________ _________ _________ _______

>

> Exciting times

>